Investment
Features
FeesSafety
Academy
More
Pluang+

CVS Health raises revenue forecast after strong Q2, analysts see 21-28% stock upside.

Analyst Insights
03 Sep 2026
Danny Green
View Source
Bullish
pluang ai news

CVS Health reported a 7.3% revenue increase in Q2 to $106.1 billion and raised its full-year revenue forecast to at least $414 billion, alongside improved earnings per share guidance. Despite UBS lowering its price target to $118, analysts like Jefferies maintain a buy rating with a $120 target, indicating 21-28% potential upside. The company is also focusing on reducing debt, supported by strong cash flow and a leverage ratio of about 3.5 times. This financial strength and analyst confidence suggest positive investment potential for CVS stock.

More News (CVS)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App